Share >  
Share
Share on Tumblr

Dr Reddys Lab

News »

   latest by relevance
Dr Reddys Labs can cross Rs 2100: Ashish Chaturmohta
May 22, 2013 at 17:55 | Source: CNBC-TV18
Ashish Chaturmohta of Fortune Equity Brokers is of the view that Dr Reddys Laboratories can cross Rs 2100 and can see a move towards Rs 2150 in this settlement.
Dr Reddy's Lab top pick in pharma: IIFL Capital
May 22, 2013 at 14:23 | Source: CNBC-TV18
Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the stocks went up 20 percent in the last couple of months itself.
Dr Reddys Labs to see deep correction: Sukhani
May 22, 2013 at 12:17 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com feels Dr Reddys Laboratories is heading for deep correction. "It has broken down from a clear trading range on the downside," he reasoned.
Buy Apollo Hospitals; target of Rs 1110: Firstcall Research
May 22, 2013 at 12:05 | Source: Moneycontrol.com
Firstcall Research is bullish on Apollo Hospitals Enterprises and has recommended buy rating on the stock with a target of Rs 1110 in its May 21, 2013 research report.
Vivimed Labs appoints Dr. V. Peesapati as additional director
May 22, 2013 at 12:03 | Source: Moneycontrol.com
Vivimed Labs has appointed Dr. V. Peesapati as an additional director (Non Executive & Independent) of the company with effect from May 22, 2013.
Market to be choppy; buy on dips, sell on rallies: Sukhani
May 22, 2013 at 09:19 | Source: CNBC-TV18
Buy on a sharp intraday dip and on a sustained rally consider going short, recommends technical analyst, Sudarshan Sukhani.

Videos »
Dr Reddys Labs can cross Rs 2100: Ashish Chaturmohta
Dr Reddys Labs to see deep correction: Sukhani
Dr Reddy's Lab top pick in pharma: IIFL Capital
Market to be choppy; buy on dips, sell on rallies: Sukhani
Lupin, Sun Pharma, Dr Reddys Labs safe bets: Tater
more »

Photos »

  /  
News across the web »
BSE Sensex sheds 112 as share sales, Fed meet weigh
Benchmark indices fell for the second successive session Tuesday, as the market is trying to digest the heady gains of the past few weeks. Brokers said share sales by promoters trying to meet the 25 ...
May 21, 2013 at 20:22 | Source: DomainB
BSE Sensex, Nifty end lower; pharma stocks take hit
Indian shares took a breather on Monday and closed marginally in red on profit booking after hitting fresh 2.5 year highs. Pharma companies dragged key equity benchmarks lower while major auto stocks...
May 21, 2013 at 06:22 | Source: DomainB
BSE Sensex crawls to new 30-month high as cap goods shine
Indices continued their upward crawl Friday, but it is clear that the market needs a bigger dose of liquidity to be able deliver meaningful returns hereon. Capital goods, power and realty shares were...
May 17, 2013 at 19:02 | Source: DomainB
BSE Sensex fails to maintain momentum, down 25 pts
BSE Sensex today failed to maintain initial gains and declined by 25 points in late morning deals due to mild profit booking in consumer durables, healthcare, capital goods and banking sectors, follo...
May 17, 2013 at 17:37 | Source: Financial Express
BSE Sensex closes slightly up; bulls pause for a breather
Shares crawled higher Thursday, as investors trade cautiously with benchmark indices quoting at their highest levels in nearly two-and-a-half years. Buyers shifted attention to mid-cap shares, as the...
May 17, 2013 at 13:47 | Source: DomainB
more »
Interact & exchange stock tips & market info »

mbansal1954

New Member

0 Follower

Consumer Non-durables - Sector  

Dr reddys Labs

7.11 PM May 21st

Market Statistician

Platinum Member

6245 Followers

Dr Reddys Labs  

There has been a block deal of 71900 shares in Dr Reddys...

12.50 PM May 20th

Aashish Tater

New Member

58 Followers

Lupin  

Will you buy Lupin, Sun Pharma, Dr Reddys Labs?

4.53 PM May 17th

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window